Mid Continent Capital’s Pfizer PFE Stock Holding History

Mid Continent Capital’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q3	$509K	Sell	17,075 -3,394	-17%	-$109K	0.03%	197
2015 Q2	$652K	Buy	20,469 +876	+4%	+$28.6K	0.04%	207
2015 Q1	$647K	Buy	19,593 +1,581	+9%	+$50.3K	0.04%	211
2014 Q4	$532K	Sell	18,012 -5,701	-24%	-$163K	0.03%	215
2014 Q3	$665K	Hold	23,713	–	–	0.04%	201
2014 Q2	$668K	Buy	23,713 +6,983	+42%	+$199K	0.04%	204
2014 Q1	$510K	Buy	16,730 +2,428	+17%	+$72.4K	0.03%	223
2013 Q4	$416K	Sell	14,302 -1,054	-7%	-$30.7K	0.03%	238
2013 Q3	$419K	Buy	15,356 +4,322	+39%	+$118K	0.03%	228
2013 Q2	$294K	Buy	+11,034	New	+$305K	0.02%	256

Other funds holding PFE

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Mid Continent Capital's PFE Position: Q3 2015 in Review

Mid Continent Capital reduced its Pfizer (PFE) stake by 17% in Q3 2015, selling an estimated $109K and leaving 17,075 shares worth $509K. The position accounts for 0.03% of the portfolio, ranked #197.

Mid Continent Capital first reported a position in PFE in Q2 2013 and has held it in 10 quarters since. The position peaked at $668K in Q2 2014. 1,880 funds tracked by Wall St. Rank hold PFE as of Q3 2015.

Mid Continent Capital held 17,075 shares of Pfizer worth $509K as of Q3 2015.
Mid Continent Capital sold 3,394 Pfizer shares in Q3 2015, an estimated $109K.
Pfizer made up 0.03% of Mid Continent Capital's portfolio in Q3 2015, its #197 holding.
Mid Continent Capital first reported a position in Pfizer in Q2 2013 and has held it in 10 quarters since.
Mid Continent Capital's Pfizer position peaked at $668K in Q2 2014.
1,880 funds tracked by Wall St. Rank held Pfizer as of Q3 2015.

Based on Mid Continent Capital's 13F filing for Q3 2015, filed 22 Oct 2015.